AIMS: To identify asthma patients who have experienced a non-consented switch (NCS) of their inhaler device and to explore the circumstances and impact of these switches. METHODS: Nineteen asthma patients who had experienced an NCS of their inhaler device were recruited to participate in qualitative, semistructured one-to-one interviews. RESULTS: All 19 participants reported a switch in their asthma inhaler without consultation or approval. There was deterioration in asthma control reported by some participants, many remained unchanged, and two reported better outcomes. Regardless of any change in asthma control, all patients expressed discontent with the NCS. Many felt it had damaged their relationship with their doctor, their confidence i...
The aim of asthma treatment is optimal disease control. Poor asthma control results in considerable ...
Pressure on healthcare budgets is increasing, while at the same time patent protection for many bran...
Inhaled therapies are central to the treatment of asthma and chronic obstructive pulmonary disease. ...
Aims: To identify asthma patients who have experienced a non-consented switch (NCS) of their inhaler...
it can have a large impact on disease control and the pa-tient’s well-being. Switching may be associ...
negative consequences of non-consented switch of inhaled medications and devices in asthma patient
The choice of an inhaler device is often as important as the medication put in it to achieve optimal...
Background As more inhaled corticosteroid (ICS) devices become available, there may be pressure for...
SummaryBackgroundPatient adherence to recommended use of ICS is questionable in asthma, with irregul...
International audienceBACKGROUND: Adherence to inhaled corticosteroids (ICS) remains a major issue f...
Objective: Management of asthma includes monitoring of inhaler technique and level of adherence to t...
This article is based on semistructured interviews and focus groups conducted with 27 asthma patient...
The Global Initiative for Asthma (GINA) has presented a shift in pharmacological asthma treatment. T...
The choice of an inhaler device is often as important as the medication put in it to achieve optimal...
INTRODUCTION: In clinical practice, it is difficult to distinguish between patients with refractory ...
The aim of asthma treatment is optimal disease control. Poor asthma control results in considerable ...
Pressure on healthcare budgets is increasing, while at the same time patent protection for many bran...
Inhaled therapies are central to the treatment of asthma and chronic obstructive pulmonary disease. ...
Aims: To identify asthma patients who have experienced a non-consented switch (NCS) of their inhaler...
it can have a large impact on disease control and the pa-tient’s well-being. Switching may be associ...
negative consequences of non-consented switch of inhaled medications and devices in asthma patient
The choice of an inhaler device is often as important as the medication put in it to achieve optimal...
Background As more inhaled corticosteroid (ICS) devices become available, there may be pressure for...
SummaryBackgroundPatient adherence to recommended use of ICS is questionable in asthma, with irregul...
International audienceBACKGROUND: Adherence to inhaled corticosteroids (ICS) remains a major issue f...
Objective: Management of asthma includes monitoring of inhaler technique and level of adherence to t...
This article is based on semistructured interviews and focus groups conducted with 27 asthma patient...
The Global Initiative for Asthma (GINA) has presented a shift in pharmacological asthma treatment. T...
The choice of an inhaler device is often as important as the medication put in it to achieve optimal...
INTRODUCTION: In clinical practice, it is difficult to distinguish between patients with refractory ...
The aim of asthma treatment is optimal disease control. Poor asthma control results in considerable ...
Pressure on healthcare budgets is increasing, while at the same time patent protection for many bran...
Inhaled therapies are central to the treatment of asthma and chronic obstructive pulmonary disease. ...